Logo Image
News
All NewsFDA UpdatesPress Releases
Watch
Expert ConversationsNews & AnalysisShows & PodcastsSponsored Webcast
Conferences
Conference CoverageConference Listing
Publications
All PublicationsPharmacy TimesPharmacy Practice in Focus: OncologyPharmacy Practice in Focus: Health SystemsPharmacy CareersAuthor SubmissionSubmit to Pharmacy Practice in Focus: OncologySubmit to Pharmacy Practice in Focus: Health SystemsBecome a Peer ReviewerSupplements & Featured Publications
More
Events
Upcoming EventsUpcoming Webinars
CE
Resources
Clinical ForumAmerican Heart MonthThe Bispecifics NetworkEducated PatientInformation for the PharmacistInteractive ToolsMicrositesPartnersPulsePointSponsoredWhiteboards

Subscribe

  • News
  • Watch
  • Conferences
  • Publications
  • Events
  • CE
  • Resources
  • Subscribe
  • 503B Compounding Pharmacy
  • Allergy
    • Asthma
  • Biosimilars
  • Cardiovascular Health
    • Heart Failure
    • Cholesterol
  • Chronic Kidney Disease
  • Classical Hematology
    • Immunoglobulins
    • Neutropenia
  • Dermatology
    • Psoriasis
    • Atopic Dermatitis
  • Endocrinology
    • Continuous Glucose Monitoring
    • Diabetes
    • Osteoporosis
  • Eye Care
    • Macular Degeneration
    • Dry Eye Disease
  • Future of Pharmacy
  • Gastrointestinal Health
    • Digestive Health
  • Hematology
    • Multiple Myeloma
    • Lymphoma
    • Myelofibrosis
    • Chronic Lymphocytic Leukemia
  • Hepatitis/MASH
  • Infectious Disease
    • Respiratory Syncytial Virus
    • Pneumococcal
    • C. difficile
    • COVID-19
    • Flu
    • HIV
    • PrEP
    • COVID Treatment
  • Neurology
    • Multiple Sclerosis
    • Alzheimer Disease
    • Epilepsy
    • Migraine
    • Sleep
    • Shingles
    • Alzheimer Disease
    • Movement Disorders
    • Parkinson Disease
  • Oncology
    • Cholangiocarcinoma
    • Endometrial Cancer
    • Immuno-oncology
    • Genitourinary Cancer
    • Lung Cancer
    • Prostate Cancer
    • Skin Cancer
    • Ovarian Cancer
    • Breast Cancer
    • Cervical Cancer
    • Gastrointestinal Cancer
    • Colorectal Cancer
    • HER2 Breast Cancer
  • Pain Management
  • Pediatrics
  • Psychiatry
    • Psychedelics
    • Schizophrenia
    • ADHD
    • Brain Health
    • Mental Health
    • Bipolar Disorder
    • Anxiety
    • Depression
  • Pulmonology
    • COPD
    • Cough and Cold
  • Rheumatology
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
  • Vaccines
    • Travel Vaccines
  • Veterinary Pharmacy
  • Vitamins and Supplements
  • Weight Management
  • Women's Health
    • Reproductive Health
Spotlight -
Community/Retail|
Hospital|
Oncology|
Pharmacy Technician|
Student
Advertisement

Christine Barrett, PharmD, BCOP

Advertisement

Articles by Christine Barrett, PharmD, BCOP

Oncology PulsePoints: Systemic Treatment of Thyroid Cancer: ASCO Guideline

ByRyu Kariyawasam-Chavez, Content Associate,Christine Barrett, PharmD, BCOP
June 4th 2026

Christine Barrett, PharmD, BCOP discusses key updates to the Systemic Treatment of Thyroid Cancer: ASCO Guideline.

Pharmacists Play Key Role in Managing Toxicity During Neoadjuvant Therapy for Melanoma

ByAlexandra Gerlach, Content Producer,Christine Barrett, PharmD, BCOP
April 12th 2025

Christine Barrett, PharmD, BCOP, shares insights, challenges, and advice for oncology pharmacists navigating neoadjuvant therapy.

Dermatologist performing exam on a patient -- Image credit: LIGHTFIELD STUDIOS | stock.adobe.com

The Role of Neoadjuvant Immunotherapy Advances in Resectable Stage III Melanoma

ByChristine Barrett, PharmD, BCOP
July 17th 2024

NADINA trial results support a new standard of care for these patients.

Advertisement

Latest Updated Articles

  • Pharmacists Play Key Role in Managing Toxicity During Neoadjuvant Therapy for Melanoma
    Pharmacists Play Key Role in Managing Toxicity During Neoadjuvant Therapy for Melanoma

    April 12th 2025

  • Oncology PulsePoints: Systemic Treatment of Thyroid Cancer: ASCO Guideline
    Oncology PulsePoints: Systemic Treatment of Thyroid Cancer: ASCO Guideline

    June 4th 2026



Advertisement
Advertisement

Trending on Pharmacy Times

1

FDA Approves First-in-Class Daraxonrasib for Metastatic Pancreatic Cancer

2

What Pharmacists Should Know About Novo Nordisk-Eli Lilly GLP-1 Ad Suit

3

FDA Approves Dolutegravir for HIV Treatment in Newborns

4

FDA Clears First Continuous Glucose-Ketone Monitor

5

FDA Grants Fast Track Designation to CK0803 for Amyotrophic Lateral Sclerosis

  • About Us
  • Clinical Forums
  • Advertise
  • Contact Us
  • Editorial Staff
  • Privacy Policy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contemporary Clinic
  • OTC Guide
  • Pharmacy Times
  • Pharmacist Mom's Group
  • Pharmacist Mom's Group
Pharmacy Times
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us